Peter M Sadow

42PUBLICATIONS
154CO-AUTHORS
Predictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Medical biotechnology diagnostics (incl. biosensors)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (42)

|Jun 10, 2026
Clinical validation of an HPV whole-genome sequencing assay for MRD detection in patients with HPV+ head and neck cancer treated with surgery.

|May 29, 2026
Correction: Pleomorphic Adenoma with Epithelial Atypia, Apocrine Metaplasia, and/or In situ/Intracapsular Salivary Duct Carcinoma Are Indolent Lesions with Good Prognosis: A Proposal for Unified Nomenclature and Clinical Observation.

|May 21, 2026
Malignant Transformation of a Radiation-Naïve Sinonasal Tract Angiofibroma: Clinicopathologic and Molecular Characterization of an Exceptionally Delayed Transformation.

|Apr 07, 2026
Thyroid Tumors of Uncertain Malignant Potential (UMP)- Clinicopathologic and Molecular Characterization of 324 Cases.

Bayan A Alzumaili, William C Faquin, Adam S Fisch

|Feb 02, 2026
Pheochromocytoma and Extra-Adrenal Paragangliomas: An Update in Diagnostics and Clinical Implications.

Priscila Dias Goncalves, Peter M Sadow

|Sep 12, 2025
Pleomorphic Adenoma with Epithelial Atypia, Apocrine Metaplasia, and/or In situ/Intracapsular Salivary Duct Carcinoma Are Indolent Lesions with Good Prognosis: A Proposal for Unified Nomenclature and Clinical Observation.

Grayson G Cole, Matt Levin, David Ferber

Pageof 7

Frequent Collaborators

14 joint publications

William C Faquin

8 joint publications

Lori Wirth

8 joint publications

Bayan Alzumaili

8 joint publications

Adam S Fisch